vs
AMERICAN SHARED HOSPITAL SERVICES(AMS)与NexPoint Real Estate Finance, Inc.(NREF)财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的1.4倍($11.1M vs $7.7M),NexPoint Real Estate Finance, Inc.净利率更高(216.6% vs -8.2%,领先224.8%),AMERICAN SHARED HOSPITAL SERVICES同比增速更快(-14.8% vs -48.8%)
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案,免除医院高昂的前期资本投入,主要业务覆盖北美,同时服务拉美及部分亚太地区的公立、私立医院客户。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业,主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案,运营并管理抵押贷款及其他地产相关投资组合,为利益相关方提供经风险调整的稳定回报。
AMS vs NREF — 直观对比
营收规模更大
NREF
是对方的1.4倍
$7.7M
营收增速更快
AMS
高出34.0%
-48.8%
净利率更高
NREF
高出224.8%
-8.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $7.7M | $11.1M |
| 净利润 | $-631.0K | $24.0M |
| 毛利率 | 11.7% | — |
| 营业利润率 | -18.1% | — |
| 净利率 | -8.2% | 216.6% |
| 营收同比 | -14.8% | -48.8% |
| 净利润同比 | 52.5% | 58.7% |
| 每股收益(稀释后) | $-0.09 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMS
NREF
| Q4 25 | $7.7M | $11.1M | ||
| Q3 25 | $7.2M | $12.5M | ||
| Q2 25 | $7.1M | $12.1M | ||
| Q1 25 | $6.1M | $11.5M | ||
| Q4 24 | $9.1M | $21.7M | ||
| Q3 24 | $7.0M | $12.5M | ||
| Q2 24 | $7.1M | $6.7M | ||
| Q1 24 | $5.2M | $-12.8M |
净利润
AMS
NREF
| Q4 25 | $-631.0K | $24.0M | ||
| Q3 25 | $-17.0K | $50.9M | ||
| Q2 25 | $-280.0K | $22.3M | ||
| Q1 25 | $-625.0K | $26.0M | ||
| Q4 24 | $-1.3M | $15.2M | ||
| Q3 24 | $-207.0K | $23.3M | ||
| Q2 24 | $3.6M | $12.1M | ||
| Q1 24 | $119.0K | $-14.6M |
毛利率
AMS
NREF
| Q4 25 | 11.7% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | 35.3% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 41.1% | — |
营业利润率
AMS
NREF
| Q4 25 | -18.1% | — | ||
| Q3 25 | -4.8% | — | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | -21.3% | — | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -12.7% | — | ||
| Q2 24 | -0.0% | — | ||
| Q1 24 | -1.6% | — |
净利率
AMS
NREF
| Q4 25 | -8.2% | 216.6% | ||
| Q3 25 | -0.2% | 407.0% | ||
| Q2 25 | -4.0% | 184.5% | ||
| Q1 25 | -10.2% | 225.6% | ||
| Q4 24 | -14.6% | 69.9% | ||
| Q3 24 | -3.0% | 186.4% | ||
| Q2 24 | 51.0% | 179.7% | ||
| Q1 24 | 2.3% | 114.3% |
每股收益(稀释后)
AMS
NREF
| Q4 25 | $-0.09 | $0.47 | ||
| Q3 25 | $0.00 | $1.14 | ||
| Q2 25 | $-0.04 | $0.54 | ||
| Q1 25 | $-0.10 | $0.70 | ||
| Q4 24 | $-0.21 | $0.71 | ||
| Q3 24 | $-0.03 | $0.74 | ||
| Q2 24 | $0.55 | $0.40 | ||
| Q1 24 | $0.02 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $31.1M |
| 总债务越低越好 | $17.4M | $771.2M |
| 股东权益账面价值 | $24.0M | $388.0M |
| 总资产 | $55.5M | $5.3B |
| 负债/权益比越低杠杆越低 | 0.72× | 1.99× |
8季度趋势,按日历期对齐
现金及短期投资
AMS
NREF
| Q4 25 | $3.5M | $31.1M | ||
| Q3 25 | $5.1M | $17.9M | ||
| Q2 25 | $11.1M | $9.1M | ||
| Q1 25 | $11.2M | $19.2M | ||
| Q4 24 | $11.0M | $3.9M | ||
| Q3 24 | $13.8M | $34.7M | ||
| Q2 24 | $14.2M | $4.3M | ||
| Q1 24 | $12.8M | $13.5M |
总债务
AMS
NREF
| Q4 25 | $17.4M | $771.2M | ||
| Q3 25 | $18.2M | $720.9M | ||
| Q2 25 | $19.1M | $815.6M | ||
| Q1 25 | $19.9M | $831.5M | ||
| Q4 24 | $20.4M | $799.3M | ||
| Q3 24 | $14.4M | $815.5M | ||
| Q2 24 | $15.1M | $861.0M | ||
| Q1 24 | $15.6M | $843.3M |
股东权益
AMS
NREF
| Q4 25 | $24.0M | $388.0M | ||
| Q3 25 | $24.6M | $375.4M | ||
| Q2 25 | $24.5M | $348.2M | ||
| Q1 25 | $24.6M | $343.7M | ||
| Q4 24 | $25.2M | $336.5M | ||
| Q3 24 | $26.4M | $335.8M | ||
| Q2 24 | $26.5M | $327.5M | ||
| Q1 24 | $22.8M | $327.1M |
总资产
AMS
NREF
| Q4 25 | $55.5M | $5.3B | ||
| Q3 25 | $59.6M | $5.3B | ||
| Q2 25 | $63.5M | $5.4B | ||
| Q1 25 | $63.3M | $5.4B | ||
| Q4 24 | $60.2M | $5.4B | ||
| Q3 24 | $63.3M | $5.7B | ||
| Q2 24 | $60.8M | $6.6B | ||
| Q1 24 | $50.1M | $7.1B |
负债/权益比
AMS
NREF
| Q4 25 | 0.72× | 1.99× | ||
| Q3 25 | 0.74× | 1.92× | ||
| Q2 25 | 0.78× | 2.34× | ||
| Q1 25 | 0.81× | 2.42× | ||
| Q4 24 | 0.81× | 2.38× | ||
| Q3 24 | 0.54× | 2.43× | ||
| Q2 24 | 0.57× | 2.63× | ||
| Q1 24 | 0.68× | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | — |
| 自由现金流率自由现金流/营收 | -34.8% | — |
| 资本支出强度资本支出/营收 | 25.7% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | $-8.5M | — |
8季度趋势,按日历期对齐
经营现金流
AMS
NREF
| Q4 25 | $-704.0K | $-4.5M | ||
| Q3 25 | $1.7M | $8.1M | ||
| Q2 25 | $-372.0K | $3.3M | ||
| Q1 25 | $2.5M | $16.0M | ||
| Q4 24 | $274.0K | $4.4M | ||
| Q3 24 | $472.0K | $14.7M | ||
| Q2 24 | $1.3M | $-7.5M | ||
| Q1 24 | $-1.9M | $17.7M |
自由现金流
AMS
NREF
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $-407.0K | — | ||
| Q2 24 | $70.0K | — | ||
| Q1 24 | $-3.0M | — |
自由现金流率
AMS
NREF
| Q4 25 | -34.8% | — | ||
| Q3 25 | -28.3% | — | ||
| Q2 25 | -32.1% | — | ||
| Q1 25 | -24.7% | — | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -58.4% | — |
资本支出强度
AMS
NREF
| Q4 25 | 25.7% | — | ||
| Q3 25 | 51.6% | — | ||
| Q2 25 | 26.9% | — | ||
| Q1 25 | 65.7% | — | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 22.7% | — |
现金转化率
AMS
NREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | 0.36× | -0.62× | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
NREF
暂无分部数据